Related references
Note: Only part of the references are listed.Interferon-Free Therapy for Genotype 1 Hepatitis C in Liver Transplant Recipients: Real-World Experience From the Hepatitis C Therapeutic Registry and Research Network
Robert S. Brown et al.
LIVER TRANSPLANTATION (2016)
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
Graham R. Foster et al.
JOURNAL OF HEPATOLOGY (2016)
Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers
Renato Romagnoli et al.
TRANSPLANT INTERNATIONAL (2016)
Timing for treatment of HCV recurrence after liver transplantation: the earlier the better
Francesco Paolo Russo et al.
TRANSPLANT INTERNATIONAL (2016)
Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Xavier Forns et al.
HEPATOLOGY (2015)
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
JOURNAL OF HEPATOLOGY (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
Adriano M. Pellicelli et al.
DIGESTIVE AND LIVER DISEASE (2014)
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
Audrey Coilly et al.
JOURNAL OF HEPATOLOGY (2014)
The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response
Roberta D'Ambrosio et al.
JOURNAL OF HEPATOLOGY (2013)
Viral Hepatitis in Liver Transplantation
Gonzalo Crespo et al.
GASTROENTEROLOGY (2012)
Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C
Tomoe Kobayashi et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
Rene Adam et al.
JOURNAL OF HEPATOLOGY (2012)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Marina Berenguer
JOURNAL OF HEPATOLOGY (2008)
Non-invasive evaluation of liver fibrosis using transient elastography
Laurent Castera et al.
JOURNAL OF HEPATOLOGY (2008)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard et al.
GASTROENTEROLOGY (2002)
The association between hepatitis C infection and survival after orthotopic liver transplantation
LM Forman et al.
GASTROENTEROLOGY (2002)
Share Paper
